Catalyst Private Wealth’s ResMed RMD Stock Holding History

Catalyst Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1	Closed	–	–	231
2020 Q3	$0	Buy	+1	New	+$185	﹤0.01%	307

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catalyst Private Wealth's RMD Position: Q4 2020 in Review

Catalyst Private Wealth sold out of ResMed (RMD) in Q4 2020, closing a stake of 1 share.

Catalyst Private Wealth first reported a position in RMD in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

Catalyst Private Wealth reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
Catalyst Private Wealth sold 1 ResMed share in Q4 2020.
Catalyst Private Wealth first reported a position in ResMed in Q3 2020 and held it in 1 quarter.
Catalyst Private Wealth's ResMed position peaked at $0 in Q3 2020.
663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Catalyst Private Wealth's 13F filing for Q4 2020, filed 5 Mar 2021.